CVasThera
Castres
About CVasThera
CVasThera is a biopharmaceutical company specializing in the development of novel therapies for cardiovascular and bowel pathologies. It holds an exclusive global license for two patents resulting from four years of joint research between INSERM (French National Institute of Health and Medical Research), the École des Mines d’Albi (a French engineering school) and the GALA platform.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.6M
- Funding stage: Seed
- Last round: Debt Financing (Mar 2021)
- Website: cvasthera.com
- Phone: +33 (0)6 69 59 45 39
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cvasthera-137867 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.